Inflammatory cytokine
An inflammatory cytokine or proinflammatory cytokine is a type of signaling molecule (a
Excessive chronic production of inflammatory cytokines contribute to
Therapies to treat inflammatory diseases include monoclonal antibodies that either neutralize inflammatory cytokines or their receptors.
Definition
An inflammatory cytokine is a type of
Inflammatory cytokines include
Function
Inflammatory cytokines play a role in initiating the inflammatory response and to regulate the host defence against pathogens mediating the
Negative impacts
Due to its proinflammatory action, a proinflammatory cytokine tends to make the disease itself or the symptoms correlated to a disease worse by causing fever, inflammation, tissue destruction, and in some cases, even shock and death.[7] Excessive amounts of proinflammatory cytokines have been shown to cause detrimental effects[2]
In the kidney
A proinflammatory cytokine affects functions of transporters and
Graft-vs-host disease
Graft-versus-host disease (GvHD) targets JAK 1 and 2, the human tyrosine kinase protein required for signaling in multiple cytokines. When these kinases are activated, signal proteins of the signal transducer and activator of transcription (STAT) protein family – which include transcription factors for target genes that serve proinflammatory roles – are phosphorylated.[9] The severity of GvHD is highly variable and is influenced by the amount of native cells present in the environment along with other regulatory T cells, TH1, TH2, or TH17 phenotypes.[10] Both CD4+ and CD8 IL-17 producing T cells have been shown to cause aTH1, causing tissue inflammation and resulting in severe GVHD.[11]
In cystic fibrosis
A proinflammatory cytokine causes hyperinflammation, the leading cause of lung tissue destruction in cystic fibrosis.[12] With such a strong inflammatory response and an elevated number of immune cells, lungs of cystic fibrosis patients cannot clear the bacteria and become more susceptible to infections. A high prevalence (40-70%) of patients with cystic fibrosis show signs of asthma, possibly due to the primary deficiency in the cystic fibrosis transmembrane conductance regulator (CFTR).[13] CFTR-deficient T-helper cells create an inflammatory environment that has high concentrations of TNF-α, IL-8, and IL-13, which contributes to increased contractility of airway smooth muscle.[citation needed]
In cardiovascular disease
Atherosclerosis induces a dysfunctional endothelium, which recruits immune cells that form lesions. Proinflammatory mediators cause inflammation after ligands in the heart vasculature activate immune cells.[14] Recent studies have shown the ability of exercise to control oxidative stress and inflammation in cardiovascular disease.[citation needed]
In adipose tissue metabolism and obesity
A proinflammatory cytokine may be present in adipose tissues. Adipocytes generate TNF-α and other interleukins. Cytokines derived from adipose tissue serve as remote regulators such as hormones. Studies have shown that TNF-α and IL-6 concentrations are elevated in obesity.[15][16][17] Obesity leaves an excess of nutrients for the body, thereby causing adipocytes to release more proinflammatory cytokines. Classically activated macrophages in the visceral fat accumulate in the fat tissues and continuously release proinflammatory cytokines, causing chronic inflammation in obese individuals.[citation needed]
In osteoarthritis
TNF-α, IL-1 and IL-6 have been found to play a pivotal role in
Fatigue
Cytokines have key roles in inflammation, which is seen as a causal mechanism in fatigue.[20][21]
Clinical implications
Reducing the biological activity of proinflammatory cytokine can reduce the brunt of attack from diseases.[7]
Blocking IL-1 or TNF-α has been highly successful in helping patients with rheumatoid arthritis,
Estrogen has been shown to promote healing by decrease the production of various proinflammatory cytokines like IL-6,[24] TNF-α,[25] and macrophage migration inhibitory factor (MIF). Increased MIF levels are often found at the site of chronic non-healing ulcers, with those levels dropping significantly with successful healing. A 2005 review of current experimental data shows that "estrogen regulates healing almost exclusively via MIF down-regulation and identifies novel MIF-regulated gene targets and clusters associated with aberrant healing." By down-regulating MIF, estrogen can promote healing, as correlated by clinical studies on aging skin and skin wounds. Unfortunately, estrogen-therapy has known carcinogenic effects[26] as mentioned by the American Cancer Society (increased incidences of breast cancer in women who undergo HRT). However, scientists could make important discoveries in the future by studying "downstream effects on genes/factors that mediate the effects of estrogen on healing."[27]
Histone deacetylate inhibitors (HDACi) can suppress proinflammatory cytokine production and reduce GvHD.[citation needed]
Some research also suggest an immunoregulatory effect of vitamin D, which has been shown to reduce the secretion of specific inflammatory cytokines.[28][29]
References
- ^ PMID 17426506.
- ^ PMID 26788465.
- PMID 11502077.
- ISBN 978-0-12-155142-1.
- PMID 26823952.
- ^ PMID 10936147.
- PMID 26508816.
- PMID 26453971.
- PMID 25934923.
- PMID 24565991.
- PMID 26857765.
- PMID 24429094.
- PMID 26791914.
- PMID 11681809.
- PMID 30591653.
- PMID 30165404.
- S2CID 53009998.
- PMID 10770646.
- PMID 28163706.
- ^ Cite error: The named reference
Tarn Evans Traianos et al 2023
was invoked but never defined (see the help page). - PMID 21530742.
- PMID 25573802.
- S2CID 24957064.
- S2CID 72334147.
- ^ "Hormone Therapy for Breast Cancer | American Cancer Society". www.cancer.org. Retrieved 2019-02-27.
- ^ "Hormonal Influences on Wound Healing: A Review of Current Experimental Data". Wounds Research. Retrieved 2019-02-27.
- S2CID 195806132.
- PMID 32804682.